News
In a turbulent market, Blackstone Inc showcased a robust Q2 2025, with a sharp increase in assets under management (AUM) and ...
Seaport Res Ptn has updated its Q3 earnings forecast for Morgan Stanley, pushing the EPS estimate from $2.03 to $2.09. This ...
UBS remains bullish on Merck, reiterating its Buy rating with a $105 price target. This optimism follows Merck's planned $10 ...
Calton & Associates trimmed its Bank of America holdings by 60.5% in Q1. They now hold 7,013 shares, worth $293,000. Other ...
Thermo Fisher Scientific Inc. just made headlines with its hefty $17.6 billion acquisition of PPD, Inc., aiming to bolster ...
Adobe's trading volume rocketed to $1.01 billion on July 24, 2025, a hefty 34.85% increase, despite a slight price drop of ...
Altus Wealth Group increased its NVIDIA holdings by 10.3% in Q1, making it their 17th largest holding. Other institutional ...
Freemont Management S.A. just made a splash, investing $2.95 million in Salesforce. But they aren't the only ones shaking ...
Alphabet reported a stellar Q2, with revenue jumping 14% to $96.4 billion. Google Cloud drove growth, increasing by 32% ...
Pfizer saw a staggering increase in call options trading, with investors snapping up 539,824 contracts, marking a 286% jump ...
JPMorgan Chase sees mixed signals as Jackson Creek Advisors boosts its stake. Other institutional investors also increased ...
Eli Lilly's Alzheimer's drug, donanemab (Kisqali), just got a thumbs-up from the European Medicines Agency's (EMA) expert ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results